BCLS Fund III Investments, LP - 30 Sep 2025 SCHEDULE 13G/A Report for CIDARA THERAPEUTICS, INC. Common Stock, $0.0001 par value per share (CDTX)

Filing Manager: BCLS Fund III Investments, LP
Reporting Manager: BCLS Fund III Investments, LP
Security: CIDARA THERAPEUTICS, INC. Common Stock, $0.0001 par value per share
Symbol: CDTX
Shares outstanding: 30.2M shares
Disclosed Ownership: 3.02M shares
Ownership: 9.99%
Form type: SCHEDULE 13G/A
Filing time: 14 Nov 2025, 16:30:03 UTC
Date of event: 30 Sep 2025
Previous filing: 14 Aug 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BCLS Fund III Investments, LP	9.99%	3.02M	0	3.02M	/s/ Andrew Hack	Andrew Hack, Partner of Bain Capital Life Sciences Investors, LLC